Rekvina Laboratories Independent Director Mr. Dhruvalkumar Jayantilal Patel Resigns Due to Personal Reasons

1 min read Updated on 09 Jan 2026, 02:00 PM

Reviewed by

Ashish TScanX News Team

Overview

Rekvina Laboratories Limited announced the resignation of Non-Executive Independent Director Mr. Dhruvalkumar Jayantilal Patel (DIN: 00448083), effective January 09, 2026, due to personal reasons. The director also stepped down from various committee memberships and confirmed no other material reasons for departure. The company has complied with SEBI regulations by informing the Bombay Stock Exchange of this board change.

*this image is generated using AI for illustrative purposes only.

Rekvina Laboratories Limited has announced the resignation of Mr. Dhruvalkumar Jayantilal Patel from his position as Non-Executive Independent Director, effective from the close of business hours on January 09, 2026. The resignation was communicated to the Bombay Stock Exchange in compliance with regulatory requirements under SEBI (LODR) Regulations, 2015.

Resignation Details

Mr. Patel, holding Director Identification Number (DIN) 00448083, submitted his resignation letter on January 09, 2026, citing personal reasons for his departure. Along with his directorship, he also resigned from his membership in various company committees where he served as a member.

Parameter	Details
Director Name	Mr. Dhruvalkumar Jayantilal Patel
DIN	00448083
Position	Non-Executive Independent Director
Reason for Change	Resignation
Effective Date	January 09, 2026

Regulatory Compliance

The company has fulfilled its disclosure obligations by informing the stock exchange pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mr. Patel confirmed in his resignation letter that there are no other material reasons for his resignation beyond the personal reasons mentioned.

Director's Other Commitments

According to the regulatory filing, Mr. Patel holds directorships in several other entities:

Avenza Pharmaceuticals Pvt Ltd.
Centurion Healthcare Pvt. Ltd.
Fabveda Wellness Pvt. Ltd.

Formal Communication

In his resignation letter addressed to the Board of Directors, Mr. Patel expressed gratitude to the Board and management for their support and cooperation during his tenure. He requested the company to take necessary steps to file required intimations with concerned authorities and acknowledge receipt of his resignation.

The resignation was signed and submitted from Vadodara on January 09, 2026. Managing Director Amit Mukesh Shah (DIN: 01993211) signed the regulatory intimation on behalf of Rekvina Laboratories Limited, ensuring proper documentation and compliance with stock exchange requirements.

Historical Stock Returns for PTC Industries